![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » BIOTICA ENTERS INTO A RESEARCH AND LICENSE AGREEMENT WITH WYETH FOR NOVEL RAPAMYCIN ANALOGS
BIOTICA ENTERS INTO A RESEARCH AND LICENSE AGREEMENT WITH WYETH FOR NOVEL RAPAMYCIN ANALOGS
Biotica Technology Ltd. a private UK biotechnology company, announced the signing of an exclusive research collaboration and license agreement with Wyeth Pharmaceuticals, a division of Wyeth. This alliance is focused on the discovery, development and commercialization of novel rapamycin analogs that target diseases in multiple therapeutic areas. Biotica (http://www.biotica.co.uk/4oct2006.htm)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct